CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Millions, unless otherwise specified	12 Months Ended
	Aug. 28, 2014	Aug. 29, 2013	Aug. 30, 2012
Cash flows from operating activities
Net income (loss)	$ 3,079	$ 1,194	$ (1,031)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation expense and amortization of intangible assets	2,103	1,804	2,141
Amortization of debt discount and other costs	167	122	81
Loss on restructure of debt	195	31	0
Stock-based compensation	115	91	87
Adjustment to gain on MMJ Acquisition	33
(Gain) on MMJ Acquisition		(1,484)	0
(Gains) losses from currency hedges, net	27	222	19
Equity in net (income) loss of equity method investees	(474)	83	294
Gain from disposition of interest in Aptina	(119)	0	0
Gain from Inotera issuance of shares	(97)	(48)	0
Noncash restructure and asset impairments	(17)	112	(6)
Change in operating assets and liabilities:
Receivables	(518)	(409)	238
Inventories	194	83	258
Accounts payable and accrued expenses	671	22	182
Deferred income taxes, net	68	(7)	3
Other noncurrent liabilities	243	(15)	(89)
Other	29	10	(63)
Net cash provided by operating activities	5,699	1,811	2,114
Cash flows from investing activities
Expenditures for property, plant and equipment	(2,658)	(1,244)	(1,699)
Purchases of available-for-sale securities	(1,063)	(924)	(564)
Payments to settle hedging activities	(26)	(253)	(62)
Additions to equity method investments	0	0	(187)
Proceeds from sales and maturities of available-for-sale securities	557	678	152
Decrease in restricted cash	536	0	5
Cash received from disposition of interest in Aptina	105	0	0
Other	96	31	43
Net cash used for investing activities	(2,453)	(1,712)	(2,312)
Cash flows from financing activities
Repayments of debt	(3,843)	(743)	(203)
Payments on equipment purchase contracts	(479)	(214)	(172)
Cash paid to purchase common stock under equity plans	(76)	(5)	(6)
Acquisition of noncontrolling interests	(18)	0	(466)
Distributions to noncontrolling interests	(10)	(37)	(391)
Proceeds from issuance of debt	2,212	1,121	1,065
Proceeds from issuance of common stock under equity plans	265	150	5
Cash received from noncontrolling interests	102	11	197
Proceeds from equipment sale-leaseback transactions	14	126	609
Other	(115)	(87)	(141)
Net cash provided by (used for) financing activities	(1,948)	322	497
Effect of changes in currency exchange rates on cash and equivalents	(28)	0	0
Net increase (decrease) in cash and equivalents	1,270	421	299
Cash and equivalents at beginning of period	2,880	2,459	2,160
Cash and equivalents at end of period	4,150	2,880	2,459
Supplemental disclosures
Income taxes refunded (paid), net	(43)	4	13
Interest paid, net of amounts capitalized	(163)	(107)	(72)
Noncash investing and financing activities:
Exchange of convertible notes	756	0	0
Equipment acquisitions on contracts payable and capital leases	587	443	897
Acquisition of noncontrolling interest	127	0	0
Conversion of notes to stock, net of unamortized issuance cost	$ 0	$ 0	$ 138